An interventional study of Physical exercise prehabilitation in Obesity and Overweight, Bariatric Surgery and Prehabilitation, sponsored by Flevoziekenhuis. Active, not recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-28.
Sponsored by Flevoziekenhuis · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn if an exercise program before bariatric surgery works to treat obesity, could improve physical condition and weight loss before bariatric surgery and induce a lifestyle behavior change. The main questions it aims to answer are:
Participants will:
3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.
This study's planned enrollment of 58 is below the median of 73 across 3,175 interventional studies indexed under Overweight.
Browse Overweight studies →Flevoziekenhuis is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with:
Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.
Behavioral: Physical exercise prehabilitation
Receives no exercise prehabilitation program
Patients in the intervention group will have two supervised training sessions per week for eight weeks in group sessions supervised by a physiotherapist.
Also known as: Prehabilitation, Exercise program
six-minute walk test
Preoperative physical condition, assessed by using the six-minute walk test (6MWT). The target increase of the 6MWT is 10% in the intervention group.
Time frame: 2 months
This study is active, not recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.